U. Karey

420 total citations
6 papers, 339 citations indexed

About

U. Karey is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, U. Karey has authored 6 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Hepatology, 4 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in U. Karey's work include Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS drug development and treatment (3 papers). U. Karey is often cited by papers focused on Hepatitis C virus research (6 papers), Hepatitis B Virus Studies (4 papers) and HIV/AIDS drug development and treatment (3 papers). U. Karey collaborates with scholars based in Germany, United States and Netherlands. U. Karey's co-authors include Christoph Sarrazin, S. Süsser, Stefan Zeuzem, Robert Ralston, Xiao Tong, Eric Hughes, Christoph Welsch, Francisco S. Domingues, Eva Herrmann and Markus Zettler and has published in prestigious journals such as Hepatology, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

U. Karey

6 papers receiving 326 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
U. Karey Germany	5	323	259	160	32	26	6	339
Markus Zettler Germany	4	256 0.8×	203 0.8×	142 0.9×	29 0.9×	25 1.0×	8	285
D. Perner Germany	9	355 1.1×	315 1.2×	108 0.7×	27 0.8×	39 1.5×	22	390
Anne Ghys United States	7	343 1.1×	285 1.1×	186 1.2×	19 0.6×	20 0.8×	11	354
Krishna Chodavarapu United States	8	335 1.0×	292 1.1×	103 0.6×	20 0.6×	27 1.0×	10	346
Eirum Chaudhri Japan	3	509 1.6×	437 1.7×	113 0.7×	60 1.9×	26 1.0×	3	531
Rob Elston United States	5	292 0.9×	263 1.0×	103 0.6×	33 1.0×	23 0.9×	7	323
J. Albrecht United States	10	391 1.2×	368 1.4×	64 0.4×	54 1.7×	33 1.3×	18	449
Ellen Xia United States	9	271 0.8×	205 0.8×	167 1.0×	13 0.4×	24 0.9×	13	296
Eileen Z. Zhang United States	8	529 1.6×	407 1.6×	303 1.9×	38 1.2×	41 1.6×	10	544
Michèle Martinot France	9	419 1.3×	418 1.6×	57 0.4×	32 1.0×	13 0.5×	15	461

Countries citing papers authored by U. Karey

Since Specialization

Citations

This map shows the geographic impact of U. Karey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by U. Karey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites U. Karey more than expected).

Fields of papers citing papers by U. Karey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by U. Karey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by U. Karey. The network helps show where U. Karey may publish in the future.

Co-authorship network of co-authors of U. Karey

This figure shows the co-authorship network connecting the top 25 collaborators of U. Karey. A scholar is included among the top collaborators of U. Karey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with U. Karey. U. Karey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Vermehren, Johannes, S. Süsser, Christian M. Lange, et al.. (2011). Mutations selected in the hepatitis C virus NS3 protease domain during sequential treatment with boceprevir with and without pegylated interferon alfa‐2b. Journal of Viral Hepatitis. 19(2). 120–127. 39 indexed citations

2.

Lange, Christian M., S. Süsser, Eva Herrmann, et al.. (2011). HVR-1 heterogeneity during treatment with telaprevir with or without pegylated interferon alfa-2a. Scandinavian Journal of Gastroenterology. 46(11). 1362–1368. 2 indexed citations

3.

Vermehren, Johannes, Giuseppe Colucci, Nabila Hamdi, et al.. (2011). Development of a Second Version of the Cobas AmpliPrep/Cobas TaqMan Hepatitis C Virus Quantitative Test with Improved Genotype Inclusivity. Journal of Clinical Microbiology. 49(9). 3309–3315. 29 indexed citations

4.

Süsser, S., Nicole Forestier, Johannes Vermehren, et al.. (2010). 771 DECLINE OF DETECTABLE RESISTANCE MUTATIONS WITHIN THE HCV NS3 PROTEASE QUASISPECIES DURING LONG-TERM FOLLOW-UP AFTER TREATMENT WITH TELAPREVIR. Journal of Hepatology. 52. S300–S300. 4 indexed citations

5.

Süsser, S., Christoph Welsch, Yalan Wang, et al.. (2009). Characterization of resistance to the protease inhibitor boceprevir in hepatitis C virus–infected patients†. Hepatology. 50(6). 1709–1718. 252 indexed citations

6.

Süsser, S., Nicole Forestier, Martin Welker, et al.. (2009). 12 DETECTION OF RESISTANT VARIANTS IN THE HEPATITIS C VIRUS NS3 PROTEASE GENE BY CLONAL SEQUENCING AT LONG-TERM FOLLOW-UP IN PATIENTS TREATED WITH BOCEPREVIR. Journal of Hepatology. 50. S7–S7. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact